Astec LifeSciences has clarified regarding recent significant stock price movements, confirming that it has consistently disclosed all necessary events and information to the stock exchanges.

The company has explicitly confirmed that there are no undisclosed developments, pending events, or material information requiring mandatory disclosure at this time.

Management remains committed to maintaining full compliance and ensuring transparency for shareholders by promptly releasing any required updates as future developments occur.